These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6907680)

  • 1. Heparin usage in chronic hemodialysis.
    Lewis LM
    Nephrol Nurse; 1981; 3(2):33, 47. PubMed ID: 6907680
    [No Abstract]   [Full Text] [Related]  

  • 2. [Early thrombocytopenia after administration of heparin in patients with chronic renal failure].
    Myśliwiec M; Kuźmicka N; Popławski A; Soszka J
    Pol Tyg Lek; 1986 Mar; 41(12):363-6. PubMed ID: 3714546
    [No Abstract]   [Full Text] [Related]  

  • 3. Hemodialysis without heparin infusion using Cordis Dow 3500 hollow fiber.
    Raja R; Kramer M; Rosenbaum JL; Bolisay C; Krug M
    Proc Clin Dial Transplant Forum; 1980; 10():39-42. PubMed ID: 7346852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The safety of heparins in end-stage renal disease.
    Sonawane S; Kasbekar N; Berns JS
    Semin Dial; 2006; 19(4):305-10. PubMed ID: 16893408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Need-adapted heparinization in hemodialysis].
    Vogel G; Kopp KF
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1563-5. PubMed ID: 1030047
    [No Abstract]   [Full Text] [Related]  

  • 6. Heparin therapy in routine hemodialysis.
    Pittard JD
    Nephrol News Issues; 2001 Apr; 15(5):73-5. PubMed ID: 12108969
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of activated coagulation time for evaluation of the degree of heparinization and calculation of heparin pharmacokinetic parameters during hemodialysis].
    Khodas MIa; Piatnitskaia GKh; Lanskaia IM; Maksimenko VA; Savina ME
    Urol Nefrol (Mosk); 1988; (3):42-8. PubMed ID: 3218006
    [No Abstract]   [Full Text] [Related]  

  • 8. [When lipids increase in dialysis: the role of heparin! Standard heparin increases, low-molecular-weight heparin lowers triglycerides].
    Wiemer J; Scherberich JE
    MMW Fortschr Med; 1999 Oct; 141(43):29-32. PubMed ID: 10912118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of heparin on lipid metabolism in patients with chronic renal failure treated with hemodialysis].
    Chmielewska J; Poplawski A
    Pol Tyg Lek; 1977 Aug; 32(34):1337-40. PubMed ID: 905179
    [No Abstract]   [Full Text] [Related]  

  • 10. [The resistance of activated partial thromboplastin time to heparin infusion during hemodialysis].
    Camici M; Sagripanti A; Barsotti G; Baicchi U; Evangelisti L; Morelli E; Giovannetti S
    Minerva Med; 1995 Sep; 86(9):353-5. PubMed ID: 7501225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dialyzer fiber bundle volume during hemodialysis using large-surface dialyzers.
    Leblanc M; Lafrance JP; Renald A
    ASAIO J; 2006; 52(6):646-51. PubMed ID: 17117054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypersensitivity to heparin; a case report.
    Katoh S; Terashima S; Nakahara Y; Yamada H; Tatsukawa H; Ida K; Nakagawa M
    Nihon Jinzo Gakkai Shi; 1993 Apr; 35(4):411-4. PubMed ID: 8341021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experiences with minimal intermittent heparinization in chronic dialysis patients].
    Kovác A; Hünicke G; Bierwisch H
    Z Urol Nephrol; 1980 May; 73(5):353-9. PubMed ID: 7456802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Kinetics of anticoagulation in hemodialysis. Sequential study of single, intermittent and continuous heparinization].
    Ghezzi PM; Di Siena F; Palanca R; Dutto A; Cento G
    Minerva Med; 1980 Oct; 71(41):2987-91. PubMed ID: 7454084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Subcutaneous calcium heparin in hemodialysis (author's transl)].
    Molinari ML; Zoni G
    Haematologica; 1975 Dec; 60(4):466-76. PubMed ID: 816716
    [No Abstract]   [Full Text] [Related]  

  • 16. [Relevance of some growth factors to cardiovascular disease in maintenance hemodialysis patients].
    Borawski J; Myśliwiec M
    Pol Merkur Lekarski; 2006 Aug; 21(122):117-8; discussion 119. PubMed ID: 17144092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a sliding scale protocol for heparin on the ability to maintain whole blood activated partial thromboplastin times within a desired range in hemodialysis patients.
    Low CL; Bailie G; Morgan S; Eisele G
    Clin Nephrol; 1996 Feb; 45(2):120-4. PubMed ID: 8846524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prothrombin time in long-term hemodialyzed patients. The effect of a single hemodialysis, heparin, protamine and vitamin K].
    Koslík S; Ponist J; Takác M; Lapsanská I
    Cas Lek Cesk; 1983 Feb; 122(5):139-42. PubMed ID: 6831493
    [No Abstract]   [Full Text] [Related]  

  • 19. Sudden collapse during haemodialysis due to immune-mediated heparin-induced thrombocytopaenia.
    Davenport A
    Nephrol Dial Transplant; 2006 Jun; 21(6):1721-4. PubMed ID: 16554318
    [No Abstract]   [Full Text] [Related]  

  • 20. Heparin leak from a hemodialysis catheter causing major bleeding, ultimately leading to transplant rejection and death.
    Dreyer G; Lawton P; Jose M
    Hemodial Int; 2008 Oct; 12(4):431-3. PubMed ID: 19090865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.